MiniPlasma: Privilege escalation 0-day affects fully patched systems
Source
ThreatLockerMiniPlasma: Privilege escalation 0-day affects fully patched systemsthreatlocker.comYou might also wanna read
Anonymous researcher releases two new Windows zero-day exploits after Patch Tuesday
An anonymous security researcher (Nightmare-Eclipse/Chaotic Eclipse) has released two new Windows zero-day exploits — YellowKey (a BitLocker
Anonymous researcher releases two new Windows zero-day exploits after Patch Tuesday
An anonymous security researcher (Nightmare-Eclipse/Chaotic Eclipse) has released two new Windows zero-day exploits — YellowKey (a BitLocker
Microsoft Defender 'RoguePlanet' zero-day exploit grants SYSTEM privileges on Windows 10 and 11
Security researcher Nightmare Eclipse has released "RoguePlanet," a zero-day exploit targeting Microsoft Defender that grants SYSTEM-level p
hendryadrian.com·28d agoRoguePlanet Zero-Day Exploit Targets Microsoft Defender, Grants SYSTEM Access on Patched Windows Systems
A proof-of-concept exploit called RoguePlanet targets a race-condition zero-day vulnerability in Microsoft Defender, granting SYSTEM-level a
Microsoft criticizes uncoordinated disclosure of six zero-day vulnerabilities
Microsoft has criticized the irresponsible disclosure of six zero-day vulnerabilities in its products, named BlueHammer, GreenPlasma, MiniPl
Microsoft zero-day feud escalates as researcher threatens major exploit release on July 14
The ongoing feud between Microsoft and security researcher Nightmare Eclipse (aka Chaotic Eclipse) has escalated, with the researcher having
Microsoft zero-day feud escalates as researcher threatens major exploit release on July 14
The ongoing feud between Microsoft and security researcher Nightmare Eclipse (aka Chaotic Eclipse) has escalated, with the researcher having
Microsoft zero-day feud escalates as researcher threatens major exploit release on July 14
The ongoing feud between Microsoft and security researcher Nightmare Eclipse (aka Chaotic Eclipse) has escalated, with the researcher having

Comments
Sign in to join the conversation.
No comments yet. Be the first.